Home Sleep Apnea Testing Devices Market Report 2025

The home sleep apnea testing devices market size has grown rapidly in recent years. It will grow from $1.79 billion in 2024 to $1.98 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth during the historic period can be attributed to the rising prevalence of sleep apnea, increasing awareness and diagnosis rates, higher incidence of related comorbid conditions, expansion in the number of sleep clinics and diagnostic centers, and growing patient preference for non-invasive testing methods.

The home sleep apnea testing devices market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing adoption of telemedicine, greater awareness among primary care physicians, a rising focus on personalized sleep therapy, growing investment in sleep research, and an expanding aging population. Key trends during this period include advancements in portable sleep monitoring devices, developments in cloud-based data management, progress in wireless and wearable technologies, integration with telemedicine platforms, and innovations in multi-parameter monitoring.

The growing prevalence of sleep disorders is expected to fuel the expansion of the home sleep apnea testing devices market in the coming years. Sleep disorders are conditions that disrupt normal sleep patterns, affecting the quality, duration, or timing of sleep and leading to daytime difficulties. Rising cases of sleep disorders are largely linked to increasing levels of stress and anxiety, which interfere with the body’s ability to relax and maintain healthy sleep cycles. Home sleep apnea testing (HSAT) devices play a key role in diagnosing these conditions by monitoring breathing patterns, airflow, and oxygen levels while patients sleep at home, enabling early detection and management of disorders such as obstructive sleep apnea. For example, in November 2023, the National Health Service (NHS) in the UK reported that 64.9% of individuals aged 17-23 experienced sleep problems on at least three nights in the previous week, a higher rate than that observed in children aged 8-16. The issue was more pronounced among young women (74.7%) compared to young men (55.7%). As a result, the rising incidence of sleep disorders is contributing to the growth of the home sleep apnea testing devices market.

Leading companies in the market are investing in technological innovations such as home-based diagnostic devices to improve patient convenience, enhance diagnostic accuracy, and enable earlier identification of sleep apnea. These home-based diagnostic tools are portable devices that allow individuals to record key health parameters - including airflow, oxygen saturation, and breathing patterns - from the comfort of their homes. This supports effective diagnosis of sleep apnea without the need for clinical settings. For instance, in April 2025, ResMed Inc., a US-based medical device company, launched NightOwl, a compact and wireless sleep apnea diagnostic solution. The device uses a disposable fingertip sensor to collect data over as many as 10 nights, offering insights into sleep variability and improving diagnostic outcomes. Benefits include easy self-application, reduced reliance on bulky equipment, minimal sleep disruption, automatic cloud-based scoring for clinician review, and a fully disposable design for convenience and infection control.

In December 2024, BodiMetrics LLC, a US-based developer of portable health and vital signs devices, partnered with EnsoData Inc. to enhance sleep apnea diagnosis and monitoring. Together, they launched an FDA-cleared wearable device that incorporates advanced AI to provide a more affordable, accessible, and accurate detection method. EnsoData Inc., a US-based healthcare technology company, develops AI-powered software aimed at improving the effectiveness of home sleep apnea testing devices.

Major players in the home sleep apnea testing devices market are Koninklijke Philips N.V., ZOLL Itamar, ResMed Inc., Nihon Kohden Corporation, Contec Medical Systems Co. Ltd., Bittium Corporation, Cadwell Industries Inc., BMC Medical Co. Ltd, SOMNOmedics AG., Compumedics Limited, Allengers Medical Systems Limited, Advanced Brain Monitoring Inc., BetterNight, Acurable Limited, ApneaMed, Belun Technology Company Limited, Braebon Medical Corporation, DormoTech Medical GmbH, Nox Medical ehf., Onera Health B.V., and PranaQ Ltd.

North America was the largest region in the home sleep apnea testing devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in home sleep apnea testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the home sleep apnea testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Home sleep apnea testing (HSAT) devices are portable diagnostic tools designed for home use to monitor airflow, oxygen saturation, and breathing patterns during sleep. They offer a convenient and cost-effective alternative to traditional in-lab sleep studies. Patients use these devices at home to record sleep-related physiological data, which is later analyzed by healthcare professionals to diagnose sleep apnea.

The primary types of HSAT devices include portable monitoring devices, home sleep tests (HST), wearable sleep trackers, and monitoring and diagnostic equipment. Portable monitoring devices are compact instruments that record sleep-related data at home to assist in detecting sleep apnea. These devices employ technologies such as oximetry, actigraphy, polysomnography, and others. HSAT devices cater to various age groups, including pediatric patients (0-17), adults (18-64), middle-aged adults (45-64), and seniors (65 and above). They are distributed via multiple channels, including direct sales, online platforms, retail pharmacies, and healthcare institutions, and serve end users such as individuals at home, healthcare providers, diagnostic laboratories, and sleep centers.

The home sleep apnea testing devices market research report is one of a series of new reports that provides home sleep apnea testing devices market statistics, including the home sleep apnea testing devices industry's global market size, regional shares, competitors with the home sleep apnea testing devices market share, detailed home sleep apnea testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the home sleep apnea testing devices market. This home sleep apnea testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The home sleep apnea testing devices market consists of sales of portable sleep monitors, nasal airflow sensors, pulse oximeters, respiratory effort belts, and snore detection sensors. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.